Opus Genetics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | +6,665.7% | -52.2% | -42.3% | +29.1% | |
| – | – | -50.0% | +0.0% | +50.0% | +66.7% | +430.0% | |
| – | – | – | +6,665.7% | -52.2% | -42.3% | +29.1% | |
| – | +180.2% | +128.2% | -5.4% | +23.0% | +52.1% | +14.8% | |
| – | +54.8% | +188.2% | -10.5% | +64.5% | +52.3% | +20.7% | |
| – | +376.2% | +16.7% | -7.2% | +36.9% | +146.7% | -27.7% | |
| – | – | – | – | -158.0% | – | – | |
| – | +385.9% | -100.0% | +350.0% | +14,655.6% | -100.0% | – | |
| – | – | – | – | -154.8% | – | – | |
| – | – | – | – | -96.2% | – | – | |
| – | – | – | – | -155.8% | – | – | |
| – | – | – | – | -154.7% | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.